As more people either  delay or seek alternative routes to starting families, fertility care has become a vital part of modern healthcare. In this episode of Health Care in Action, Boston IVF CEO David Stern takes us inside the cutting-edge world of in-vitro fertilization (IVF). Learn how advancements in embryo culture, genetic testing, and AI are improving success rates and creating personalized treatment plans. David also shares how Boston IVF’s innovative approach to patient care is making fertility treatment more accessible and breaking down common barriers like cost, travel, and stigma. 

Key takeaways from this episode:

• How advancements in embryo culture and genetic testing have dramatically improved success rates while reducing risks like multiple births
• How Boston IVF's hub-and-spoke model makes treatment more accessible and convenient, addressing common barriers like cost and travel time
• How new technologies like AI and customized patient management systems are reshaping the IVF landscape
• Why addressing the stigma of infertility is important to bridging the communication gap between patients and practitioners 

To learn more about THL’s cross-sector strategy to uncover opportunities in emerging technologies, visit THL.com/automation